Cytoreductive surgery with intraperitoneal chemotherapy to treat pseudomyxoma peritonei at nonspecialized hospitals

[1]  H. Järvinen,et al.  Survival of patients with pseudomyxoma peritonei treated by serial debulking , 2010, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[2]  T. Chua,et al.  Evaluation of the Cost-Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (Peritonectomy) at the St George Hospital Peritoneal Surface Malignancy Program , 2010, Annals of surgery.

[3]  J. Esquivel,et al.  Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy , 2009, Journal of surgical oncology.

[4]  G. Fiorentini,et al.  Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience. , 2009, In vivo.

[5]  T. Chua,et al.  Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei , 2009, Journal of surgical oncology.

[6]  J. Esquivel,et al.  Morbidity and Mortality of 109 Consecutive Cytoreductive Procedures with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Performed at a Community Hospital , 2009, World Journal of Surgery.

[7]  T. Goi,et al.  PATIENTS AND METHODS , 1980 .

[8]  H. Nagawa,et al.  Signet ring cell carcinoma of the appendix manifesting as colonic obstruction and ovarian tumors: Report of a case , 2009, Surgery Today.

[9]  Yan Li,et al.  Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival in Selected Patients with Peritoneal Carcinomatosis from Abdominal and Pelvic Malignancies: Results of 21 Cases , 2009, Annals of Surgical Oncology.

[10]  B. Moran,et al.  Consensus statement on the loco‐regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei) , 2008, Journal of surgical oncology.

[11]  S. Laurberg,et al.  Quality of Life After Cytoreductive Surgery plus Early Intraperitoneal Postoperative Chemotherapy for Pseudomyxoma Peritonei: A Prospective Study , 2008, Diseases of the colon and rectum.

[12]  F. Zoetmulder,et al.  Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy , 2007, Annals of surgery.

[13]  H. Ito,et al.  Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer. , 2007, Cancer treatment and research.

[14]  C. Chou,et al.  Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei. , 2007, Hepato-gastroenterology.

[15]  PhD B. L. van Leeuwen MD,et al.  Swedish Experience with Peritonectomy and HIPEC. HIPEC in Peritoneal Carcinomatosis , 2007, Annals of Surgical Oncology.

[16]  P. Sugarbaker,et al.  A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei , 2007, Annals of Surgical Oncology.

[17]  K. Geisinger,et al.  Pseudomyxoma Peritonei of Appendiceal Origin: A Clinicopathologic Analysis of 101 Patients Uniformly Treated at a Single Institution, With Literature Review , 2006, The American journal of surgical pathology.

[18]  J. Esquivel,et al.  Prospective Morbidity and Mortality Assessment of Cytoreductive Surgery Plus Perioperative Intraperitoneal Chemotherapy To Treat Peritoneal Dissemination of Appendiceal Mucinous Malignancy , 2006, Annals of Surgical Oncology.

[19]  L. Oñate-Ocaña,et al.  Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement , 2006, Annals of Surgical Oncology.

[20]  H. Schlitt,et al.  Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei , 2005, International Journal of Colorectal Disease.

[21]  P. Sugarbaker,et al.  Incomplete Cytoreduction in 174 Patients With Peritoneal Carcinomatosis From Appendiceal Malignancy , 2004, Annals of surgery.

[22]  S. Andreola,et al.  Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP): A Strategy That Has Confirmed its Efficacy in Patients with Pseudomyxoma Peritonei , 2004, Annals of Surgical Oncology.

[23]  P. Royle,et al.  Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei. , 2004, Health technology assessment.

[24]  S. Barsky,et al.  Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. , 2002, The American journal of pathology.

[25]  P. Sugarbaker.  The subpyloric space: an important surgical and radiologic feature in pseudomyxoma peritonei. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[26]  J. Esquivel,et al.  Second-Look Surgery in Patients With Peritoneal Dissemination From Appendiceal Malignancy: Analysis of Prognostic Factors in 98 Patients , 2001, Annals of surgery.

[27]  R. Kurman,et al.  Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis , 2001, Cancer.

[28]  P. Sugarbaker,et al.  Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy , 1999, Annals of Surgical Oncology.

[29]  P. Sugarbaker.  Peritonectomy procedures. , 1996, Cancer treatment and research.

[30]  P. H. Sugarbaker,et al.  Pseudomyxoma peritonei syndrome. , 1996, Advances in surgery.

[31]  A. Huvos,et al.  Pseudomyxoma peritonei of appendiceal origin. The memorial sloan‐kettering cancer center experience , 1992, Cancer.

[32]  J. Cleland,et al.  PSEUDOMYXOMA PERITONEI OF APPENDICEAL ORIGIN AND MUCOCELE OF THE APPENDIX , 1927 .